Compass Therapeutics, Inc.

NASDAQ:CMPX

1.7 (USD) • At close November 4, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018
Operating Activities:
Net Income -42.494-39.225-82.181-29.5-34.744-38.286
Depreciation & Amortization 1.891.9041.6242.4042.121.921
Deferred Income Tax 0050.5760.8370.109-0.261
Stock Based Compensation 6.125.334.0294.0160.9150.656
Change In Working Capital -2.908-1.2636.245-3.6-0.2572.17
Accounts Receivables 000000
Inventory 000000
Accounts Payables 0.7082.515-0.1940.432-1.1010.992
Other Working Capital -3.616-3.7786.439-4.0320.8441.178
Other Non Cash Items 5.966-0.8710.041-0.960.1160.121
Operating Cash Flow -40.618-34.125-19.666-26.803-31.741-33.679
Investing Activities:
Investments In Property Plant And Equipment -0.03-0.212-1.568-0.106-0.466-2.02
Acquisitions Net 00.1760.1160.14400
Purchases Of Investments -155.418-200.1190000
Sales Maturities Of Investments 182.41348.9550000
Other Investing Activites 0.027-0.151-0.318000
Investing Cash Flow 26.965-151.2-1.770.038-0.466-2.02
Financing Activities:
Debt Repayment 00-9.375-5.6250-14.954
Common Stock Issued 3.09476.237128.26760.482049.077
Common Stock Repurchased -000000
Dividends Paid 000000
Other Financing Activities -0.159-0.48-0.281-6.3190.03864.031
Financing Cash Flow 2.93575.757118.61148.5380.03864.031
Other Information:
Effect Of Forex Changes On Cash 0000-0.0380
Net Change In Cash -10.718-109.56897.17521.773-32.20728.332
Cash At End Of Period 24.22834.946144.51447.33925.56657.773